Blue Advantage Advanced Imaging Policies
Click here to return to the Blue Advantage Advanced Imaging Policies page
Draft Genetic Testing Policies - Blue Advantage
Blue Cross and Blue Shield of Alabama partners with Carelon Medical Benefits Management, an independent company, to administer genetic testing solutions for our customers.
Carelon is our business associate and has agreed to follow our privacy and security policies regarding the confidentiality and protection of your personal health information.
Draft Genetic Testing Policies
Effective for dates of service on or after June 15, 2025, the changes listed in the document below will apply to Carelon Genetic Testing Clinical Appropriateness Guidelines. As part of the Carelon guidelines semi-annual review process, these updates are focused on advancing efforts to drive clinically appropriate, safe and affordable healthcare services.
Clicking "Accept" will take you to a website operated by Carelon Medical Benefits Management.
Comment on Draft Policies
To ensure that the development of medical policies occurs through an open, collaborative process, we welcome comments about medical policies that are in the draft stage.
Participating providers are invited to submit scientific, evidence-based information, professional consensus opinions and other information supported by medical literature relevant to these draft policies for consideration.
Comments are accepted for 45 days from the posting date listed on the draft policy.
Make sure your voice is heard by providing feedback directly to us:
- Complete our online medical policy feedback form, or
- Send comments by mail or fax to:
Blue Cross and Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001
Fax: 205-220-0878
Blue Advantage Draft Imaging Policies
We partner with Carelon Medical Benefits Management to administer advanced imaging solutions for our members.
Note: Coverage is subject to member's specific benefits. Group-specific policies will supersede these policies when applicable. Please refer to member's benefit plan.
Draft Imaging Policies
There are no policies currently in draft status.
Comment on Draft Imaging Policies
To ensure that the development of medical policies occurs through an open, collaborative process, we welcome comments about medical policies that are in the draft stage. Our current draft policies are listed below.
Providers are invited to submit scientific, evidence-based information, professional consensus opinions and other information supported by medical literature relevant to draft policies for consideration.
Comments are accepted for 45 days from the posting date listed on the draft policy.
How to Submit Comments
Make sure your voice is heard by providing feedback directly to us:
- Complete our online medical policy feedback form, or
- Send comments by mail or fax to:
- Medical Director's Office
Blue Cross Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001 - Fax: 205-220-0878
- Medical Director's Office
Blue Advantage Genetic Testing Policies
Click here to return to the Blue Advantage Genetic Testing Policies page
Blue Advantage Radiation Therapy Policies
Click here to return to the Blue Advantage Radiation Therapy Policies page
Draft Radiation Therapy Policies - Blue Advantage
Blue Cross and Blue Shield of Alabama partners with eviCore Healthcare (formerly CareCore National LLC) to administer radiation therapy solutions for our customers.
EviCore is our business associate and is an independent company that provides specialty benefit management services. EviCore has agreed to follow our privacy and security policies regarding the confidentiality and protection of personal health information.
Draft Radiation Therapy Policies
Effective for dates of service on and after July 15, 2025, the following updates will apply to the eviCore Radiation Oncology Guidelines.
Summary of Changes to eviCore Radiation Oncology Guidelines Effective July 15, 2025
Comment on Draft Policies
To ensure that the development of medical policies occurs through an open, collaborative process, we welcome comments about medical policies that are in the draft stage. Our current draft policies are listed below.
Participating providers and other providers are invited to submit scientific, evidence-based information, professional consensus opinions and other information supported by medical literature relevant to these draft policies for consideration. We accept comments for 45 days from the posting date listed on the draft policy document.
Note: Coverage is subject to member's specific benefits. Group-specific policies will supersede these policies when applicable. Please refer to member's benefit plan.
Participating providers can comment on draft policies online or via mail or fax:
How to Submit Comments
Participating providers can comment on draft policies online or via mail or fax:
- Complete our medical policy feedback form
- Send comments by mail or fax to:
Blue Cross Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001
Fax: 205-220-0878